James Annis

1.4k citations

16 papers · 1.0k indexed · 1 hit paper · h-index 9

Impact in

Molecular Biology top 10%
- CRISPR and Genetic Engineering
- Renal and related cancers
- Pluripotent Stem Cells Research
- Ubiquitin and proteasome pathways
- DNA Repair Mechanisms
Aging

Papers in ⓘ

Aging 1
Molecular Biology 13
- Ubiquitin and proteasome pathways 3
- Protein Degradation and Inhibitors 2
- Glycosylation and Glycoproteins Research 2
- DNA Repair Mechanisms 2
- Cancer-related gene regulation 2
- Pluripotent Stem Cells Research 2

Co-authors: Andrew M. Scharenberg (1 shared paper)Byoung Y. Ryu (1 shared paper)David J. Rawlings (1 shared paper)Jordan Jarjour (1 shared paper)Michael T. Certo (1 shared paper)Peter S. Linsley (3 shared papers)Carla Grandori (5 shared papers)Randall T. Moon (2 shared papers)
Journals: Nature Methods (1 paper)Clinical Cancer Research (1 paper)Scientific Reports (1 paper)PLoS ONE (1 paper)Cancer Prevention Research (1 paper)
Partner nations: United States South Africa India

In The Last Decade

James Annis

16 papers receiving 1.0k citations

Hit Papers

align trajectories log scale

High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping 2018 · 329 citations

Peers

Countries citing papers authored by James Annis

Since Specialization

Citations

This map shows the geographic impact of James Annis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Annis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Annis more than expected).

Fields of papers citing papers by James Annis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Annis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Annis. The network helps show where James Annis may publish in the future.

Co-authors

The 25 scholars most cited alongside James Annis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with James Annis Line = papers co-authored together James Annis links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work
1	High-Throughput Screening Enhances Kidney Organoid Differentiation from Human Pluripotent Stem Cells and Enables Automated Multidimensional Phenotyping Cell stem cell ·Stefan Czerniecki, Nelly M. Cruz, Jennifer L. Harder, Rajasree Menon, James Annis, Edgar A. Otto, Ramila E. Gulieva, Laura Islas, Yong Kyun Kim, Linh M. Tran, Timothy J. Martins, Jeffrey W. Pippin, Hongxia Fu, Matthias Kretzler, Stuart J. Shankland, Jonathan Himmelfarb, Randall T. Moon, Neal Paragas, Benjamin Freedman Hit paper breakdown →	2018	329
2	Tracking genome engineering outcome at individual DNA breakpoints Nature Methods ·Michael T. Certo, Byoung Y. Ryu, James Annis, Mikhail Garibov, Jordan Jarjour, David J. Rawlings, Andrew M. Scharenberg	2011	231
3	Functional genomics identifies therapeutic targets for MYC-driven cancer Proceedings of the National Academy of Sciences ·Masafumi Toyoshima, Heather L. Howie, Maki Imakura, Ryan Walsh, James Annis, Aaron N. Chang, Jason P. Frazier, B. Nelson Chau, Andrey Loboda, Peter S. Linsley, Michele A. Cleary, Julie R. Park, Carla Grandori	2012	197
4	RNA Interference-Mediated Silencing of Mitotic Kinesin KIF14 Disrupts Cell Cycle Progression and Induces Cytokinesis Failure Molecular and Cellular Biology ·Michael Carleton, Mao Mao, Matthew C. Biery, Paul Warrener, Sammy Kim, Carolyn A. Buser, C. Gary Marshall, Christine Fernandes, James Annis, Peter S. Linsley	2006	100
5	Functional Kinomics Identifies Candidate Therapeutic Targets in Head and Neck Cancer Clinical Cancer Research ·Russell Moser, Chang Xu, Michael Kao, James Annis, Luisa Angelica Lerma, Christopher M. Schaupp, Kay E. Gurley, In Sock Jang, Asel Biktasova, Wendell G. Yarbrough, (unknown), Carla Grandori, Christopher J. Kemp, Eduardo Méndez	2014	66
6	PPP2R2C Loss Promotes Castration-Resistance and Is Associated with Increased Prostate Cancer-Specific Mortality Molecular Cancer Research ·Eric G. Bluemn, Elysia Sophie Spencer, Brigham H. Mecham, Ryan R. Gordon, Ilsa M. Coleman, Daniel Lewinshtein, Elahe A. Mostaghel, Xiaotun Zhang, James Annis, Carla Grandori, Christopher R. Porter, Peter S. Nelson	2013	36
7	Identification of Putative Immunologic Targets for Colon Cancer Prevention Based on Conserved Gene Upregulation from Preinvasive to Malignant Lesions Cancer Prevention Research ·Elizabeth K. Broussard, Rachel Kim, Jesse C. Wiley, Juan Pablo Márquez-Manríquez, James Annis, David K. Pritchard, Mary L. Disis	2013	23
8	A Lentivirus-Mediated Genetic Screen Identifies Dihydrofolate Reductase (DHFR) as a Modulator of β-Catenin/GSK3 Signaling PLoS ONE ·Richard A. Klinghoffer, Jason P. Frazier, James Annis, Jason D. Berndt, Brian S. Roberts, William T. Arthur, Raul Lacson, Xiaohua Douglas Zhang, Marc Ferrer, Randall T. Moon, Michele A. Cleary	2009	16
9	An Optimized Lentivirus-Mediated RNAi Screen Reveals Kinase Modulators of Kinesin-5 Inhibitor Sensitivity Assay and Drug Development Technologies ·Richard A. Klinghoffer, Brian S. Roberts, James Annis, Jason P. Frazier, Patrick A. Lewis, Peter S. Linsley, Michele A. Cleary	2008	8
10	Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients npj Breast Cancer ·Sasha E. Stanton, Ekram Gad, Erik Ramos, Lauren R. Corulli, James Annis, Jennifer S. Childs, Hiroyuki Katayama, Samir Hanash, Jeffrey R. Marks, Mary L. Disis	2021	7
11	Inactivating Mutations in Exonuclease and Polymerase Domains in DNA Polymerase Delta Alter Sensitivities to Inhibitors of dNTP Synthesis DNA and Cell Biology ·Jiaming Zhang, Deyin Hou, James Annis, Forough Sargolzaeiaval, Julia Appelbaum, Eishi Takahashi, George M. Martin, Alan J. Herr, Junko Oshima	2019	5
12	Pharmacologic Targeting of TFIIH Suppresses KRAS-Mutant Pancreatic Ductal Adenocarcinoma and Synergizes with TRAIL Cancer Research ·Russell Moser, James Annis, Olga Nikolova, Cliff Whatcott, Kay E. Gurley, Eduardo Méndez, Kim Moran‐Jones, Craig Dorrell, Rosalie C. Sears, Calvin J. Kuo, Haiyong Han, Andrew V. Biankin, Carla Grandori, Daniel D. Von Hoff, Christopher J. Kemp	2022	4
13	Negative regulation of initial steps in skeletal myogenesis by mTOR and other kinases Scientific Reports ·Raphael A. Wilson, Jing Liu, Lin Xu, James Annis, Sara Helmig, Gregory L. Moore, Casey Timmerman, Carla Grandori, Yanbin Zheng, Stephen X. Skapek	2016	4
14	Characterization of GRK5 as a novel regulator of rhabdomyosarcoma tumor cell growth and self-renewal Oncotarget ·Thao Pham, Kristin Robinson, Terra Vleeshouwer-Neumann, James Annis, Eleanor Y. Chen	2020	4
15	High Throughput Drug Screening of Leukemia Stem Cells Reveals Resistance to Standard Therapies and Sensitivity to Other Agents in Acute Myeloid Leukemia Blood ·F. Linzee Mabrey, Sylvia Chien, Timothy S Martins, James Annis, Taylor Sekizaki, Jin Dai, Robert A. Beckman, Lawrence A. Loeb, Andrew R. Carson, Bradley Patay, C. Anthony Blau, Vivian G. Oehler, Safiye Çelik, Su‐In Lee, Raymond J. Monnat, Janis L. Abkowitz, Frederick R. Appelbaum, Elihu H. Estey, Pamela S. Becker	2018	3
16	Cell-to-Cell Variation in Gene Expression for Cultured Human Cells Is Controlled in Trans by Diverse Genes: Implications for the Pathobiology of Aging The Journals of Gerontology Series A ·Jiaming Zhang, Nikolay Burnaevskiy, James Annis, Wenyan Han, Deyin Hou, Paula D. Ladd, Lin Lee, Alexander Mendenhall, Junko Oshima, George M. Martin	2020	3

About James Annis

James Annis is a scholar working on Aging, Molecular Biology, Cancer Research, Cell Biology and Neurology, having authored 16 papers that have together received 1.0k indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (3 papers), Protein Degradation and Inhibitors (2 papers), Glycosylation and Glycoproteins Research (2 papers), Microtubule and mitosis dynamics (2 papers), Cancer-related Molecular Pathways (2 papers), DNA Repair Mechanisms (2 papers), Cancer-related gene regulation (2 papers) and Pluripotent Stem Cells Research (2 papers). The work is most often cited by research in Molecular Biology (869 citations), Aging (16 citations), Oncology (246 citations), Cell Biology (120 citations) and Cancer Research (98 citations). James Annis has collaborated with scholars based in United States, South Africa and India. Frequent co-authors include Andrew M. Scharenberg, Byoung Y. Ryu, David J. Rawlings, Jordan Jarjour, Michael T. Certo, Peter S. Linsley, Carla Grandori, Randall T. Moon, Jason P. Frazier and Michele A. Cleary. Their work appears in journals such as Nature Methods, Clinical Cancer Research, Scientific Reports, PLoS ONE and Cancer Prevention Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact